

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.08102906 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.07860295 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.84305465 |
| 4 | vocalization behavior (GO:0071625) | 4.63900184 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.55709002 |
| 6 | protein localization to synapse (GO:0035418) | 4.48476147 |
| 7 | righting reflex (GO:0060013) | 4.45480576 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.38749076 |
| 9 | inositol phosphate catabolic process (GO:0071545) | 4.30229456 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.26988054 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.19269287 |
| 12 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.14657744 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 4.12532291 |
| 14 | glutamate secretion (GO:0014047) | 4.07438034 |
| 15 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.89413284 |
| 16 | inositol phosphate dephosphorylation (GO:0046855) | 3.89413284 |
| 17 | insulin secretion (GO:0030073) | 3.87843806 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.87619408 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.87083482 |
| 20 | detection of calcium ion (GO:0005513) | 3.84890415 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.83092960 |
| 22 | response to pheromone (GO:0019236) | 3.81605039 |
| 23 | behavioral response to ethanol (GO:0048149) | 3.81321496 |
| 24 | synaptic vesicle maturation (GO:0016188) | 3.78512023 |
| 25 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.70802568 |
| 26 | regulation of hexokinase activity (GO:1903299) | 3.70774378 |
| 27 | regulation of glucokinase activity (GO:0033131) | 3.70774378 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.67793085 |
| 29 | nucleobase catabolic process (GO:0046113) | 3.66386420 |
| 30 | locomotory exploration behavior (GO:0035641) | 3.62497226 |
| 31 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.60838976 |
| 32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.59392147 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.59261887 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.58114583 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 3.57226743 |
| 36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54671020 |
| 37 | positive regulation of action potential (GO:0045760) | 3.52533332 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.52240070 |
| 39 | synaptic vesicle endocytosis (GO:0048488) | 3.50951945 |
| 40 | neuron fate determination (GO:0048664) | 3.44903642 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43505611 |
| 42 | positive regulation of synapse maturation (GO:0090129) | 3.42101660 |
| 43 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.33439211 |
| 44 | postsynaptic membrane organization (GO:0001941) | 3.32094387 |
| 45 | regulation of vesicle fusion (GO:0031338) | 3.31944043 |
| 46 | exploration behavior (GO:0035640) | 3.30030142 |
| 47 | proline transport (GO:0015824) | 3.28286449 |
| 48 | neuron recognition (GO:0008038) | 3.27566396 |
| 49 | endocrine pancreas development (GO:0031018) | 3.25172668 |
| 50 | neurotransmitter transport (GO:0006836) | 3.25018222 |
| 51 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24850183 |
| 52 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.24223714 |
| 53 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.23984136 |
| 54 | protein localization to cilium (GO:0061512) | 3.23783399 |
| 55 | fear response (GO:0042596) | 3.23518227 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.21279449 |
| 57 | polyol catabolic process (GO:0046174) | 3.21227369 |
| 58 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.19898693 |
| 59 | synapse assembly (GO:0007416) | 3.19599343 |
| 60 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.15848294 |
| 61 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.14970771 |
| 62 | auditory behavior (GO:0031223) | 3.14844344 |
| 63 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.14579906 |
| 64 | synaptic vesicle transport (GO:0048489) | 3.13871677 |
| 65 | establishment of synaptic vesicle localization (GO:0097480) | 3.13871677 |
| 66 | response to auditory stimulus (GO:0010996) | 3.13660647 |
| 67 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.12274805 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.12025378 |
| 69 | nitric oxide mediated signal transduction (GO:0007263) | 3.11735611 |
| 70 | innervation (GO:0060384) | 3.10500326 |
| 71 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.10135176 |
| 72 | retinal ganglion cell axon guidance (GO:0031290) | 3.09944293 |
| 73 | regulation of synapse structural plasticity (GO:0051823) | 3.09591858 |
| 74 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.06587551 |
| 75 | axonal fasciculation (GO:0007413) | 3.05732871 |
| 76 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.05044012 |
| 77 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.05044012 |
| 78 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.04738293 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 3.04209509 |
| 80 | positive regulation of insulin secretion (GO:0032024) | 3.02161581 |
| 81 | membrane hyperpolarization (GO:0060081) | 3.01215634 |
| 82 | regulation of postsynaptic membrane potential (GO:0060078) | 3.00531206 |
| 83 | negative regulation of dendrite development (GO:2000171) | 2.99433487 |
| 84 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.99054908 |
| 85 | transmission of nerve impulse (GO:0019226) | 2.98368921 |
| 86 | glycerophospholipid catabolic process (GO:0046475) | 2.98143299 |
| 87 | layer formation in cerebral cortex (GO:0021819) | 2.96700048 |
| 88 | behavioral fear response (GO:0001662) | 2.95189389 |
| 89 | behavioral defense response (GO:0002209) | 2.95189389 |
| 90 | response to histamine (GO:0034776) | 2.95174062 |
| 91 | long-term synaptic potentiation (GO:0060291) | 2.94660759 |
| 92 | regulation of neurotransmitter levels (GO:0001505) | 2.91895562 |
| 93 | cell migration in hindbrain (GO:0021535) | 2.91276673 |
| 94 | mating behavior (GO:0007617) | 2.91266220 |
| 95 | nonmotile primary cilium assembly (GO:0035058) | 2.91254738 |
| 96 | long-term memory (GO:0007616) | 2.91180518 |
| 97 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90963588 |
| 98 | cellular potassium ion homeostasis (GO:0030007) | 2.89446992 |
| 99 | positive regulation of synapse assembly (GO:0051965) | 2.88050066 |
| 100 | positive regulation of membrane potential (GO:0045838) | 2.87320376 |
| 101 | startle response (GO:0001964) | 2.87212302 |
| 102 | presynaptic membrane organization (GO:0097090) | 2.87035927 |
| 103 | dendritic spine morphogenesis (GO:0060997) | 2.86695131 |
| 104 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.85711233 |
| 105 | mechanosensory behavior (GO:0007638) | 2.82307723 |
| 106 | regulation of synapse maturation (GO:0090128) | 2.81979130 |
| 107 | glycosphingolipid biosynthetic process (GO:0006688) | 2.80959330 |
| 108 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.80939045 |
| 109 | peptide hormone secretion (GO:0030072) | 2.79734607 |
| 110 | striatum development (GO:0021756) | 2.79035610 |
| 111 | prepulse inhibition (GO:0060134) | 2.78886336 |
| 112 | negative regulation of norepinephrine secretion (GO:0010700) | 2.78605006 |
| 113 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.78141866 |
| 114 | membrane depolarization during action potential (GO:0086010) | 2.77772335 |
| 115 | response to dietary excess (GO:0002021) | 2.77050292 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.76055820 |
| 117 | cAMP-mediated signaling (GO:0019933) | 2.76019642 |
| 118 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.75894009 |
| 119 | synapse organization (GO:0050808) | 2.75578513 |
| 120 | potassium ion export (GO:0071435) | 2.75366736 |
| 121 | establishment of vesicle localization (GO:0051650) | 2.75291794 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 2.75089524 |
| 123 | synaptic transmission (GO:0007268) | 2.73925271 |
| 124 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.72492491 |
| 125 | regulation of synapse assembly (GO:0051963) | 2.72377839 |
| 126 | signal peptide processing (GO:0006465) | 2.71865045 |
| 127 | regulation of insulin secretion (GO:0050796) | 2.71631887 |
| 128 | peptide secretion (GO:0002790) | 2.71134167 |
| 129 | positive regulation of peptide hormone secretion (GO:0090277) | 2.69627931 |
| 130 | behavioral response to nicotine (GO:0035095) | 2.69315918 |
| 131 | regulation of action potential (GO:0098900) | 2.66805908 |
| 132 | epithelial cell fate commitment (GO:0072148) | 2.66537760 |
| 133 | positive regulation of mitochondrial fission (GO:0090141) | 2.65186173 |
| 134 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.64631488 |
| 135 | positive regulation of glycolytic process (GO:0045821) | 2.63372568 |
| 136 | establishment of melanosome localization (GO:0032401) | 2.62750543 |
| 137 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.62105324 |
| 138 | positive regulation of peptide secretion (GO:0002793) | 2.61709819 |
| 139 | neuronal action potential (GO:0019228) | 2.58856206 |
| 140 | lactate metabolic process (GO:0006089) | 2.58808120 |
| 141 | brain morphogenesis (GO:0048854) | 2.58111487 |
| 142 | dendritic spine organization (GO:0097061) | 2.56017738 |
| 143 | peptide hormone processing (GO:0016486) | 2.55059231 |
| 144 | melanosome transport (GO:0032402) | 2.54044967 |
| 145 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.50799847 |
| 146 | signal release (GO:0023061) | 2.49930959 |
| 147 | calcium ion import (GO:0070509) | 2.49026905 |
| 148 | intraciliary transport (GO:0042073) | 2.48187075 |
| 149 | regulation of peptide hormone secretion (GO:0090276) | 2.48037014 |
| 150 | establishment of pigment granule localization (GO:0051905) | 2.47576735 |
| 151 | protein targeting to Golgi (GO:0000042) | 2.46945874 |
| 152 | alanine transport (GO:0032328) | 2.44996180 |
| 153 | regulation of neurotransmitter uptake (GO:0051580) | 2.44034349 |
| 154 | dentate gyrus development (GO:0021542) | 2.43863762 |
| 155 | regulation of peptide secretion (GO:0002791) | 2.42572037 |
| 156 | chemosensory behavior (GO:0007635) | 2.40618641 |
| 157 | serotonin metabolic process (GO:0042428) | 2.40500519 |
| 158 | establishment of protein localization to Golgi (GO:0072600) | 2.39599491 |
| 159 | pigment granule transport (GO:0051904) | 2.38577148 |
| 160 | spinal cord motor neuron differentiation (GO:0021522) | 2.38199772 |
| 161 | auditory receptor cell differentiation (GO:0042491) | 2.37129771 |
| 162 | regulation of feeding behavior (GO:0060259) | 2.36994941 |
| 163 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.36573364 |
| 164 | protein localization to Golgi apparatus (GO:0034067) | 2.36268359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.20130867 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.03621956 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89858579 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.69876804 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61387633 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.55341903 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54024892 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29200786 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.28795511 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.21205402 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.20825558 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19922305 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17721085 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16822325 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16822325 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13343331 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.12592060 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.11538388 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09725471 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.08578555 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00893928 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.00827798 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98910475 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93878034 |
| 25 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93335023 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.88589530 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.88261703 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87466808 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.86617361 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85458250 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85246547 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.84052985 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80705220 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79622121 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77205560 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74727357 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72773154 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.71965309 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.69332412 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.67939004 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.67820670 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66027086 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60614989 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60599683 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59042998 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.55939511 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.53133612 |
| 48 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48380548 |
| 49 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.48163408 |
| 50 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45889774 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45329794 |
| 52 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.42813566 |
| 53 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.42576880 |
| 54 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42013879 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41517874 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40441017 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40429725 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40233980 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36938794 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36920739 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36535504 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35174387 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30963877 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30963877 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28478947 |
| 66 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26874273 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26232794 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25619616 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25143674 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25036785 |
| 71 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.24978174 |
| 72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.24160505 |
| 73 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22775111 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21438156 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21242648 |
| 76 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21111148 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20679310 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19516783 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18357599 |
| 80 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.17815204 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17739697 |
| 82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16992527 |
| 83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16117139 |
| 84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15991701 |
| 85 | * AR_19668381_ChIP-Seq_PC3_Human | 1.15683434 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15584898 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14247546 |
| 88 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13163561 |
| 89 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13108401 |
| 90 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13108401 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.11290767 |
| 92 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10993560 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10302142 |
| 94 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09278377 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08993384 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08935658 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08685876 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08385524 |
| 99 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07907712 |
| 100 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07426557 |
| 101 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07050124 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06984878 |
| 103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06292173 |
| 104 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05463796 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05254975 |
| 106 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04612969 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04529004 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03964271 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03889082 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 1.03270599 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03128427 |
| 112 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02766978 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02326306 |
| 114 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02273205 |
| 115 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01752253 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01489840 |
| 117 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00764275 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00264081 |
| 119 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99634071 |
| 120 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99634071 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99296230 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98654842 |
| 123 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94055962 |
| 124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93990026 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93868043 |
| 126 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.93367505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.29275773 |
| 2 | MP0003880_abnormal_central_pattern | 3.77154868 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.43448225 |
| 4 | MP0004270_analgesia | 3.19064187 |
| 5 | MP0002063_abnormal_learning/memory/cond | 2.81338797 |
| 6 | MP0010386_abnormal_urinary_bladder | 2.77884365 |
| 7 | MP0009745_abnormal_behavioral_response | 2.70968145 |
| 8 | MP0006276_abnormal_autonomic_nervous | 2.66672123 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.66125019 |
| 10 | MP0001529_abnormal_vocalization | 2.65306080 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.61652678 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.51211206 |
| 13 | MP0002064_seizures | 2.49553949 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.48476841 |
| 15 | MP0002736_abnormal_nociception_after | 2.39991083 |
| 16 | MP0009046_muscle_twitch | 2.34729564 |
| 17 | MP0002272_abnormal_nervous_system | 2.19872317 |
| 18 | MP0001486_abnormal_startle_reflex | 2.18781627 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.14359527 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.06189911 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.03069176 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.02623533 |
| 23 | MP0002184_abnormal_innervation | 1.97702903 |
| 24 | MP0001188_hyperpigmentation | 1.96123152 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.95403687 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.94287862 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.92219055 |
| 28 | MP0001970_abnormal_pain_threshold | 1.86620536 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.85781641 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.82906455 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.82862107 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.82586243 |
| 33 | MP0004043_abnormal_pH_regulation | 1.81008960 |
| 34 | MP0003195_calcinosis | 1.76924796 |
| 35 | MP0001984_abnormal_olfaction | 1.76680302 |
| 36 | MP0000778_abnormal_nervous_system | 1.76043416 |
| 37 | MP0001905_abnormal_dopamine_level | 1.74505546 |
| 38 | MP0003787_abnormal_imprinting | 1.73805485 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.73300942 |
| 40 | MP0004924_abnormal_behavior | 1.73300942 |
| 41 | MP0002822_catalepsy | 1.70914257 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.67388273 |
| 43 | MP0003122_maternal_imprinting | 1.66356341 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.61130292 |
| 45 | MP0002163_abnormal_gland_morphology | 1.60740026 |
| 46 | MP0004885_abnormal_endolymph | 1.58697955 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.56543406 |
| 48 | MP0000631_abnormal_neuroendocrine_gland | 1.53853233 |
| 49 | MP0002102_abnormal_ear_morphology | 1.50331179 |
| 50 | MP0006292_abnormal_olfactory_placode | 1.43844053 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.40506264 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.38305773 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.35534518 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.35377193 |
| 55 | MP0002139_abnormal_hepatobiliary_system | 1.35086379 |
| 56 | MP0000955_abnormal_spinal_cord | 1.34821960 |
| 57 | MP0008569_lethality_at_weaning | 1.33218818 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.30058542 |
| 59 | MP0003879_abnormal_hair_cell | 1.23668305 |
| 60 | MP0004858_abnormal_nervous_system | 1.22812661 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.21811483 |
| 62 | MP0000516_abnormal_urinary_system | 1.20324543 |
| 63 | MP0005367_renal/urinary_system_phenotyp | 1.20324543 |
| 64 | MP0002090_abnormal_vision | 1.17837964 |
| 65 | MP0004133_heterotaxia | 1.16460634 |
| 66 | MP0002928_abnormal_bile_duct | 1.16345354 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 1.14908425 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.08912967 |
| 69 | MP0002938_white_spotting | 1.08756511 |
| 70 | MP0002152_abnormal_brain_morphology | 1.08127486 |
| 71 | MP0005253_abnormal_eye_physiology | 1.07761360 |
| 72 | MP0004147_increased_porphyrin_level | 1.06342045 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 1.02070124 |
| 74 | MP0003329_amyloid_beta_deposits | 1.01800948 |
| 75 | MP0004142_abnormal_muscle_tone | 1.00751868 |
| 76 | MP0003121_genomic_imprinting | 0.98124471 |
| 77 | MP0005448_abnormal_energy_balance | 0.97535851 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.96386289 |
| 79 | MP0003283_abnormal_digestive_organ | 0.95636595 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.94205995 |
| 81 | MP0004215_abnormal_myocardial_fiber | 0.94064883 |
| 82 | MP0001756_abnormal_urination | 0.93594389 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.90351474 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.88962979 |
| 85 | MP0003011_delayed_dark_adaptation | 0.88572284 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.88184939 |
| 87 | MP0005187_abnormal_penis_morphology | 0.88157658 |
| 88 | MP0004085_abnormal_heartbeat | 0.86729941 |
| 89 | MP0003953_abnormal_hormone_level | 0.85701813 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.85227116 |
| 91 | MP0005499_abnormal_olfactory_system | 0.85227116 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.84796254 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.84192790 |
| 94 | MP0000427_abnormal_hair_cycle | 0.83867162 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.83482236 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.82808273 |
| 97 | MP0002229_neurodegeneration | 0.82552865 |
| 98 | MP0004233_abnormal_muscle_weight | 0.82420933 |
| 99 | MP0005535_abnormal_body_temperature | 0.82246961 |
| 100 | MP0005379_endocrine/exocrine_gland_phen | 0.82218138 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.82176608 |
| 102 | MP0001664_abnormal_digestion | 0.82108289 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.81735607 |
| 104 | MP0001944_abnormal_pancreas_morphology | 0.80436275 |
| 105 | MP0005332_abnormal_amino_acid | 0.76677356 |
| 106 | MP0008877_abnormal_DNA_methylation | 0.76302582 |
| 107 | MP0004742_abnormal_vestibular_system | 0.75920184 |
| 108 | MP0000462_abnormal_digestive_system | 0.73593100 |
| 109 | MP0003631_nervous_system_phenotype | 0.73438278 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.73222933 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.72991247 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.72784046 |
| 113 | MP0003634_abnormal_glial_cell | 0.71426428 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.71005907 |
| 115 | MP0000678_abnormal_parathyroid_gland | 0.70796902 |
| 116 | MP0003633_abnormal_nervous_system | 0.70314863 |
| 117 | MP0003861_abnormal_nervous_system | 0.70012963 |
| 118 | MP0008260_abnormal_autophagy | 0.69051587 |
| 119 | MP0003632_abnormal_nervous_system | 0.68238051 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.66477533 |
| 121 | MP0000026_abnormal_inner_ear | 0.65620956 |
| 122 | MP0001299_abnormal_eye_distance/ | 0.65577621 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.64653553 |
| 124 | MP0002234_abnormal_pharynx_morphology | 0.64223955 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.64003585 |
| 126 | MP0003890_abnormal_embryonic-extraembry | 0.63005919 |
| 127 | MP0008872_abnormal_physiological_respon | 0.62474327 |
| 128 | MP0003123_paternal_imprinting | 0.62165951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.63913136 |
| 2 | Atonic seizures (HP:0010819) | 4.82442993 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.30487922 |
| 4 | Myokymia (HP:0002411) | 4.18851074 |
| 5 | Febrile seizures (HP:0002373) | 4.08219412 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.03207651 |
| 7 | Focal seizures (HP:0007359) | 4.02269492 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.93160036 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.92990904 |
| 10 | Visual hallucinations (HP:0002367) | 3.86352082 |
| 11 | Absence seizures (HP:0002121) | 3.73621752 |
| 12 | Ketoacidosis (HP:0001993) | 3.52568265 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.52198230 |
| 14 | Decreased circulating renin level (HP:0003351) | 3.40036493 |
| 15 | Large for gestational age (HP:0001520) | 3.32736073 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.21238065 |
| 17 | Dialeptic seizures (HP:0011146) | 3.07327693 |
| 18 | Methylmalonic acidemia (HP:0002912) | 3.01504213 |
| 19 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.98939793 |
| 20 | Intestinal atresia (HP:0011100) | 2.95529714 |
| 21 | Hypothermia (HP:0002045) | 2.91711854 |
| 22 | Abnormal hair whorl (HP:0010721) | 2.90404345 |
| 23 | Abnormality of the labia minora (HP:0012880) | 2.82051886 |
| 24 | Hyperglycemia (HP:0003074) | 2.81582714 |
| 25 | Abnormality of vitamin B metabolism (HP:0004340) | 2.72643800 |
| 26 | Broad-based gait (HP:0002136) | 2.70462448 |
| 27 | Limb dystonia (HP:0002451) | 2.68319682 |
| 28 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.67899151 |
| 29 | Excessive salivation (HP:0003781) | 2.66805581 |
| 30 | Drooling (HP:0002307) | 2.66805581 |
| 31 | Progressive macrocephaly (HP:0004481) | 2.63788106 |
| 32 | Epileptiform EEG discharges (HP:0011182) | 2.60350122 |
| 33 | Ankle clonus (HP:0011448) | 2.59276060 |
| 34 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54845349 |
| 35 | Hyperactive renin-angiotensin system (HP:0000841) | 2.51979224 |
| 36 | Nephronophthisis (HP:0000090) | 2.50719183 |
| 37 | Amblyopia (HP:0000646) | 2.49359611 |
| 38 | Depression (HP:0000716) | 2.47291385 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 2.46780474 |
| 40 | Failure to thrive in infancy (HP:0001531) | 2.46732716 |
| 41 | Truncal ataxia (HP:0002078) | 2.46258043 |
| 42 | Enlarged penis (HP:0000040) | 2.45149113 |
| 43 | Gait imbalance (HP:0002141) | 2.44406017 |
| 44 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.44261716 |
| 45 | Polyphagia (HP:0002591) | 2.42859715 |
| 46 | Hyperventilation (HP:0002883) | 2.42008704 |
| 47 | Pheochromocytoma (HP:0002666) | 2.41484368 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 2.40953032 |
| 49 | Muscular hypotonia of the trunk (HP:0008936) | 2.39570589 |
| 50 | Chronic bronchitis (HP:0004469) | 2.38350362 |
| 51 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.37955047 |
| 52 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.37955047 |
| 53 | Agitation (HP:0000713) | 2.37788155 |
| 54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.35912288 |
| 55 | Symptomatic seizures (HP:0011145) | 2.35594386 |
| 56 | Ketosis (HP:0001946) | 2.34539369 |
| 57 | Late onset (HP:0003584) | 2.34387696 |
| 58 | Pancreatic cysts (HP:0001737) | 2.34226022 |
| 59 | Hypsarrhythmia (HP:0002521) | 2.34194244 |
| 60 | Progressive inability to walk (HP:0002505) | 2.33366699 |
| 61 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.32000242 |
| 62 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.32000242 |
| 63 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.31532178 |
| 64 | Poor eye contact (HP:0000817) | 2.29222907 |
| 65 | Gaze-evoked nystagmus (HP:0000640) | 2.28409514 |
| 66 | Abnormal eating behavior (HP:0100738) | 2.28116438 |
| 67 | Methylmalonic aciduria (HP:0012120) | 2.25422800 |
| 68 | Blue irides (HP:0000635) | 2.24388598 |
| 69 | Genetic anticipation (HP:0003743) | 2.23328255 |
| 70 | Abnormality of vitamin metabolism (HP:0100508) | 2.23151592 |
| 71 | Pancreatic fibrosis (HP:0100732) | 2.21324344 |
| 72 | Hemiparesis (HP:0001269) | 2.21313477 |
| 73 | Anxiety (HP:0000739) | 2.19463520 |
| 74 | Dysdiadochokinesis (HP:0002075) | 2.17673614 |
| 75 | Hypomagnesemia (HP:0002917) | 2.16863277 |
| 76 | Scanning speech (HP:0002168) | 2.16819089 |
| 77 | Hepatic necrosis (HP:0002605) | 2.15354150 |
| 78 | Action tremor (HP:0002345) | 2.13803620 |
| 79 | Prolonged QT interval (HP:0001657) | 2.10923602 |
| 80 | Congenital primary aphakia (HP:0007707) | 2.09283989 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 2.07548690 |
| 82 | Poor suck (HP:0002033) | 2.06826685 |
| 83 | Fetal akinesia sequence (HP:0001989) | 2.06756749 |
| 84 | Abnormality of the metopic suture (HP:0005556) | 2.06346024 |
| 85 | Urinary urgency (HP:0000012) | 2.05747666 |
| 86 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05547128 |
| 87 | Absent speech (HP:0001344) | 2.05531655 |
| 88 | Papillary thyroid carcinoma (HP:0002895) | 2.04821082 |
| 89 | Mitochondrial inheritance (HP:0001427) | 2.02807466 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.02738738 |
| 91 | Central scotoma (HP:0000603) | 2.02687903 |
| 92 | Prominent metopic ridge (HP:0005487) | 2.01235004 |
| 93 | Abnormality of the renal medulla (HP:0100957) | 2.00554156 |
| 94 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00000253 |
| 95 | Mutism (HP:0002300) | 1.99575056 |
| 96 | Intention tremor (HP:0002080) | 1.99348778 |
| 97 | Abnormal social behavior (HP:0012433) | 1.99114558 |
| 98 | Impaired social interactions (HP:0000735) | 1.99114558 |
| 99 | Inability to walk (HP:0002540) | 1.98613599 |
| 100 | Postural tremor (HP:0002174) | 1.98586231 |
| 101 | Molar tooth sign on MRI (HP:0002419) | 1.98087072 |
| 102 | Abnormality of midbrain morphology (HP:0002418) | 1.98087072 |
| 103 | Abnormality of macular pigmentation (HP:0008002) | 1.97024357 |
| 104 | Abnormality of the renal cortex (HP:0011035) | 1.96579993 |
| 105 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.96535979 |
| 106 | Type II lissencephaly (HP:0007260) | 1.96012261 |
| 107 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95555004 |
| 108 | Congenital malformation of the right heart (HP:0011723) | 1.95161567 |
| 109 | Double outlet right ventricle (HP:0001719) | 1.95161567 |
| 110 | Torticollis (HP:0000473) | 1.94229432 |
| 111 | Abnormality of salivation (HP:0100755) | 1.94190597 |
| 112 | Hepatoblastoma (HP:0002884) | 1.92172156 |
| 113 | Spastic gait (HP:0002064) | 1.91660655 |
| 114 | True hermaphroditism (HP:0010459) | 1.91629744 |
| 115 | Menstrual irregularities (HP:0000858) | 1.91120451 |
| 116 | Dysmetria (HP:0001310) | 1.90119869 |
| 117 | Poor coordination (HP:0002370) | 1.89629368 |
| 118 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.88773608 |
| 119 | Genital tract atresia (HP:0001827) | 1.88032711 |
| 120 | Hypoventilation (HP:0002791) | 1.87417658 |
| 121 | Esotropia (HP:0000565) | 1.86948842 |
| 122 | Hyperkalemia (HP:0002153) | 1.86379704 |
| 123 | Abnormality of the fovea (HP:0000493) | 1.84944095 |
| 124 | Clonus (HP:0002169) | 1.84726354 |
| 125 | Glycosuria (HP:0003076) | 1.83285741 |
| 126 | Abnormality of urine glucose concentration (HP:0011016) | 1.83285741 |
| 127 | Abnormal drinking behavior (HP:0030082) | 1.81708352 |
| 128 | Polydipsia (HP:0001959) | 1.81708352 |
| 129 | Vaginal atresia (HP:0000148) | 1.80039627 |
| 130 | Epidermoid cyst (HP:0200040) | 1.79908668 |
| 131 | Acute encephalopathy (HP:0006846) | 1.79291222 |
| 132 | Thyroid carcinoma (HP:0002890) | 1.78113901 |
| 133 | Impaired smooth pursuit (HP:0007772) | 1.78018900 |
| 134 | Specific learning disability (HP:0001328) | 1.77944381 |
| 135 | Increased CSF lactate (HP:0002490) | 1.77627595 |
| 136 | Hyperthyroidism (HP:0000836) | 1.77351575 |
| 137 | Generalized myoclonic seizures (HP:0002123) | 1.77138371 |
| 138 | Renal cortical cysts (HP:0000803) | 1.76304429 |
| 139 | Papilledema (HP:0001085) | 1.74587270 |
| 140 | Labial hypoplasia (HP:0000066) | 1.74384585 |
| 141 | Impaired vibratory sensation (HP:0002495) | 1.74155620 |
| 142 | Termporal pattern (HP:0011008) | 1.73798272 |
| 143 | Insidious onset (HP:0003587) | 1.73798272 |
| 144 | Diplopia (HP:0000651) | 1.72343432 |
| 145 | Abnormality of binocular vision (HP:0011514) | 1.72343432 |
| 146 | Narrow nasal bridge (HP:0000446) | 1.71808315 |
| 147 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.71456345 |
| 148 | Hypoplasia of the fovea (HP:0007750) | 1.71456345 |
| 149 | Focal dystonia (HP:0004373) | 1.70918176 |
| 150 | Anteriorly placed anus (HP:0001545) | 1.70401327 |
| 151 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.70312449 |
| 152 | Hypoplasia of the brainstem (HP:0002365) | 1.70312449 |
| 153 | Spastic tetraplegia (HP:0002510) | 1.70270733 |
| 154 | Neurofibrillary tangles (HP:0002185) | 1.69662082 |
| 155 | Protruding tongue (HP:0010808) | 1.68814501 |
| 156 | Exotropia (HP:0000577) | 1.68648274 |
| 157 | Incomplete penetrance (HP:0003829) | 1.67470531 |
| 158 | Abnormality of the corticospinal tract (HP:0002492) | 1.67333290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.61331372 |
| 2 | MAP3K9 | 3.30244261 |
| 3 | MARK1 | 3.24781956 |
| 4 | MAP3K4 | 2.84325293 |
| 5 | MAP2K7 | 2.70997901 |
| 6 | CASK | 2.65983847 |
| 7 | FGFR2 | 2.44470339 |
| 8 | MINK1 | 2.41243505 |
| 9 | MAP4K2 | 2.40832855 |
| 10 | EPHA4 | 2.39051592 |
| 11 | PRKD3 | 2.28885679 |
| 12 | MAP3K12 | 2.18708876 |
| 13 | MAPK13 | 2.16702114 |
| 14 | KSR2 | 2.16498779 |
| 15 | KSR1 | 2.09760586 |
| 16 | PAK6 | 2.07768950 |
| 17 | EPHA3 | 2.01208388 |
| 18 | PRPF4B | 2.01193313 |
| 19 | TNIK | 2.00662914 |
| 20 | AKT3 | 1.89310121 |
| 21 | NTRK2 | 1.80562596 |
| 22 | MAP2K4 | 1.80286836 |
| 23 | BRAF | 1.73597847 |
| 24 | LATS2 | 1.65661255 |
| 25 | ADRBK2 | 1.61011343 |
| 26 | MAP3K6 | 1.60927939 |
| 27 | TRIM28 | 1.59266584 |
| 28 | SIK3 | 1.57064986 |
| 29 | NTRK1 | 1.53923834 |
| 30 | ARAF | 1.52524800 |
| 31 | UHMK1 | 1.45717565 |
| 32 | MAP2K6 | 1.38426199 |
| 33 | SGK494 | 1.36796482 |
| 34 | SGK223 | 1.36796482 |
| 35 | CSNK1G1 | 1.35150913 |
| 36 | SGK2 | 1.31294844 |
| 37 | PLK2 | 1.29372883 |
| 38 | GRK1 | 1.28001178 |
| 39 | BCR | 1.25760346 |
| 40 | GRK5 | 1.21653883 |
| 41 | MAP3K2 | 1.15138686 |
| 42 | FGFR3 | 1.14436187 |
| 43 | CDK5 | 1.13771826 |
| 44 | MST4 | 1.13190308 |
| 45 | DYRK2 | 1.11478785 |
| 46 | PASK | 1.09595506 |
| 47 | CDK19 | 1.06336496 |
| 48 | DYRK1A | 1.01390996 |
| 49 | CAMKK2 | 1.01278124 |
| 50 | DAPK2 | 0.99261636 |
| 51 | PAK3 | 0.97496505 |
| 52 | CSNK1A1L | 0.95928941 |
| 53 | RAF1 | 0.95856434 |
| 54 | STK38L | 0.95489709 |
| 55 | CAMK2A | 0.91203879 |
| 56 | ERBB3 | 0.88853507 |
| 57 | CSNK1G2 | 0.88151067 |
| 58 | PRKCG | 0.88057210 |
| 59 | CDK18 | 0.87905815 |
| 60 | PNCK | 0.87288356 |
| 61 | CDK14 | 0.86579632 |
| 62 | FRK | 0.86459136 |
| 63 | STK38 | 0.85924819 |
| 64 | DAPK1 | 0.85890384 |
| 65 | RET | 0.81857974 |
| 66 | MAP3K1 | 0.80973890 |
| 67 | ADRBK1 | 0.80426777 |
| 68 | MUSK | 0.79802235 |
| 69 | ERBB4 | 0.78217988 |
| 70 | CDK15 | 0.78195718 |
| 71 | SIK2 | 0.77655634 |
| 72 | WNK3 | 0.76348714 |
| 73 | PHKG1 | 0.76274704 |
| 74 | PHKG2 | 0.76274704 |
| 75 | PRKCE | 0.74375543 |
| 76 | PINK1 | 0.74270437 |
| 77 | OXSR1 | 0.74161662 |
| 78 | CAMKK1 | 0.73412156 |
| 79 | MAP3K13 | 0.72397115 |
| 80 | STK11 | 0.72012562 |
| 81 | CAMK2B | 0.71978049 |
| 82 | SGK3 | 0.70962950 |
| 83 | LATS1 | 0.70473769 |
| 84 | BMPR2 | 0.69975070 |
| 85 | INSRR | 0.65646162 |
| 86 | PRKAA1 | 0.63186208 |
| 87 | CDK11A | 0.63023624 |
| 88 | TYRO3 | 0.62991252 |
| 89 | MKNK2 | 0.60883399 |
| 90 | IRAK2 | 0.60471720 |
| 91 | CAMK1 | 0.59959811 |
| 92 | MARK2 | 0.59104266 |
| 93 | RPS6KA2 | 0.58387631 |
| 94 | CAMK1G | 0.58107596 |
| 95 | OBSCN | 0.55794137 |
| 96 | BRSK1 | 0.55600943 |
| 97 | SGK1 | 0.55283760 |
| 98 | CAMK2D | 0.54848911 |
| 99 | PRKCZ | 0.54735516 |
| 100 | PKN1 | 0.54655707 |
| 101 | MAP2K1 | 0.53658901 |
| 102 | STK3 | 0.52923727 |
| 103 | PRKG1 | 0.52922459 |
| 104 | CCNB1 | 0.52527866 |
| 105 | PRKACA | 0.52222192 |
| 106 | TRPM7 | 0.52177806 |
| 107 | TAOK1 | 0.51223607 |
| 108 | CSNK1G3 | 0.50877933 |
| 109 | HIPK2 | 0.50679342 |
| 110 | NLK | 0.48290447 |
| 111 | CSNK1A1 | 0.47425273 |
| 112 | FER | 0.47066126 |
| 113 | LIMK1 | 0.46764742 |
| 114 | CDK3 | 0.45768697 |
| 115 | STK39 | 0.44873514 |
| 116 | CDK8 | 0.44438370 |
| 117 | LMTK2 | 0.43141536 |
| 118 | PRKACB | 0.41835213 |
| 119 | GRK7 | 0.41499104 |
| 120 | CSNK1D | 0.41365615 |
| 121 | BMPR1B | 0.41189713 |
| 122 | RPS6KA3 | 0.39272500 |
| 123 | WNK4 | 0.38493151 |
| 124 | WNK1 | 0.37803039 |
| 125 | PRKAA2 | 0.37155068 |
| 126 | PRKCH | 0.36956752 |
| 127 | PLK3 | 0.36388331 |
| 128 | CDC42BPA | 0.35911086 |
| 129 | MAPK10 | 0.35720936 |
| 130 | CAMK2G | 0.35720412 |
| 131 | PRKCA | 0.34333147 |
| 132 | STK24 | 0.32513244 |
| 133 | BCKDK | 0.32469865 |
| 134 | MAP3K5 | 0.30029447 |
| 135 | CSNK1E | 0.29893616 |
| 136 | PRKACG | 0.29219697 |
| 137 | CAMK1D | 0.27008669 |
| 138 | YES1 | 0.25193755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.00269167 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.40173467 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.77079893 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70760470 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.49164527 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.41101572 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.33926080 |
| 8 | Taste transduction_Homo sapiens_hsa04742 | 2.33650198 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 2.30652248 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.30215840 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.24204200 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14703752 |
| 13 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.13117001 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.09482228 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.09146059 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.96167369 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.94106595 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84863058 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78687096 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.76114889 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.71089008 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66350080 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60818763 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.59540906 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58461209 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47597127 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45706761 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.43565939 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42839256 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42563064 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.42110238 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40460986 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40453542 |
| 34 | * Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38342055 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.36878193 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34633947 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.31749802 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31345054 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27852844 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.25789602 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20547918 |
| 42 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.19549950 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18856104 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10981454 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07694537 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06504804 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03957901 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02461020 |
| 49 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.01571965 |
| 50 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01073028 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99632678 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96500925 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96186898 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95436897 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94239952 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.93853790 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93571965 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90407362 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86030253 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.85188968 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84906026 |
| 62 | * Peroxisome_Homo sapiens_hsa04146 | 0.84410796 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.84187052 |
| 64 | Alcoholism_Homo sapiens_hsa05034 | 0.83023076 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.81419921 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81075578 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81037146 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80151237 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78725303 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78295253 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77129398 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76807012 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76776313 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76092736 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73979009 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73941189 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73826800 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72046238 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71271876 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69928123 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.69786464 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69481152 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66456081 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66345099 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65762925 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65724945 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64094998 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63438455 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63148654 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62783402 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62643901 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.62283064 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62240596 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60992106 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60420410 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.60369265 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59550612 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58523088 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57343193 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57174978 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57111760 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56295327 |
| 103 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55016311 |
| 104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54337611 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53173551 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52845549 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52519749 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50419026 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.50340464 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49611484 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48971757 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48533740 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48185934 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47823993 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47300293 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46320740 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46156433 |
| 118 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44688943 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44554370 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43860038 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43023206 |
| 122 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41848060 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41057410 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38426844 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37108583 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36955162 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35656447 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.34711347 |
| 129 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.34231202 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34094895 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33701057 |
| 132 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33193773 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32315006 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32300720 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31512773 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31438851 |
| 137 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30333106 |

